Novel triple therapy in ITP provides enduring responses

For patients with chronic primary immune thrombocytopenia, a three-drug regimen was associated with a high response rate and relapse-free survival, according to the results of a single-arm, phase IIb trial published online in Blood. Twenty patients with primary immune thrombocytopenia (ITP)...
Source: Skin and Allergy News - Category: Dermatology Source Type: news